ReviewBiotech (Basel (Switzerland))2022

Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV.

Julian J Freen-van HeerenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.